Ascletis’ ritonavir eyes marketing authorisation in Europe

March 4, 2022

According to research, Gilead’s long-acting HIV medication is superior to Truvada

June 21, 2024

Cerevel Reports Phase 3 Parkinson’s Success

April 21, 2024

Must Read

Gilead Secures Arenavirus Vaccine Programs from Hookipa for $10 Million

May 27, 2025

Sanofi Acquires Vigil Neuroscience for $470M to Boost Alzheimer’s Drug Pipeline

May 27, 2025

Moderna Delays Flu-COVID Combo Vaccine Filing Amid FDA Request

May 22, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

New Data Positions Immutep’s Immunotherapy Combo as First-Line Option for PD-L1-Negative HNSCC

BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts

Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic

Moderna Delays Flu-COVID Combo Vaccine Filing Amid FDA Request

Boehringer’s Nerandomilast Advances in IPF Amid Analyst Reservations

Vertex Presses Pause on CF Study, Reports Major Write-Down

J&J Gene Therapy Treatment For Vision Loss Fails to Meet Primary Endpoints

Gilead Secures Arenavirus Vaccine Programs from Hookipa for $10 Million

Sanofi Acquires Vigil Neuroscience for $470M to Boost Alzheimer’s Drug Pipeline

CellCentric Secures $120M Series C Funding to Advance Myeloma Drug Inobrodib

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

The Future of Gene Therapies: Three Trends

Jan Wehkamp

Janssen reports positive topline results for Tremfya in Crohn’s at week...

Editor Picks

Ascletis’ ritonavir eyes marketing authorisation in Europe

According to research, Gilead’s long-acting HIV medication is superior to Truvada

Cerevel Reports Phase 3 Parkinson’s Success

Must Read

Gilead Secures Arenavirus Vaccine Programs from Hookipa for $10 Million

Sanofi Acquires Vigil Neuroscience for $470M to Boost Alzheimer’s Drug Pipeline

Moderna Delays Flu-COVID Combo Vaccine Filing Amid FDA Request

Hot Topics

About Us

Follow Us